Your browser doesn't support javascript.
loading
Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry.
Boegemann, Martin; Schlack, Katrin; Rink, Michael; Bernhardt, Stephan; Moran, Michael; Hubbe, Marcus; Bergmann, Lothar; Schmid, Marianne; Strauss, Arne.
Affiliation
  • Boegemann M; Klinik für Urologie und Kinderurologie, Universitätsklinikum Münster, Münster, Germany, & West German Cancer Center, University Hospital of Muenster, Muenster, Germany.
  • Schlack K; Klinik für Urologie und Kinderurologie, Universitätsklinikum Münster, Münster, Germany, & West German Cancer Center, University Hospital of Muenster, Muenster, Germany.
  • Rink M; Klinik und Poliklinik für Urologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Bernhardt S; Pfizer Pharma GmbH, Berlin, Germany.
  • Moran M; Pfizer Pharma GmbH, Berlin, Germany.
  • Hubbe M; Pfizer Pharma GmbH, Berlin, Germany.
  • Bergmann L; Medizinische Klinik 2, Universitätsklinikum Frankfurt, Frankfurt, Germany.
  • Schmid M; Klinik für Urologie, Universitätsmedizin Göttingen, Göttingen, Germany.
  • Strauss A; Klinik für Urologie, Universitätsmedizin Göttingen, Göttingen, Germany.
Future Oncol ; 16(35): 2939-2948, 2020 Dec.
Article in En | MEDLINE | ID: mdl-33021843
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Sunitinib / Kidney Neoplasms Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Future Oncol Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Sunitinib / Kidney Neoplasms Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Future Oncol Year: 2020 Document type: Article Affiliation country: Country of publication: